Skip to main content
Premium Trial:

Request an Annual Quote

Neogen Buys GeneSeek for $13.8M

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Food and livestock safety diagnostics company Neogen has bought agricultural genetics firm GeneSeek through a stock purchase valued at roughly $13.8 million, Neogen said today.

The full price for GeneSeek, which earned revenues of approximately $12.5 million in 2009, will depend on contingent payments based on its performance, Neogen said.

GeneSeek uses Illumina's Infinium BeadChip and Sequenom's MassArray technologies to conduct DNA genotyping to identify and analyze traits that are important for disease resistance and meat quality.

Neogen said that it expects to retain all of Lincoln, Neb.-based GeneSeek's employees in its current facilities.

Lansing, Mich.-based Neogen has an animal safety division that markets diagnostics, veterinary instruments, pharmaceuticals and related tools, and a food safety division that offers testing for bacteria, allergens, drugs, and plant diseases.

"Neogen has added to its genomic capability during the past year to speed the development of food and animal safety diagnostic tests, as well as develop novel intervention tools to solve food and animal safety problems," Neogen Chairman and CEO James Herbert said in a statement.

The Scan

Not as High as Hoped

The Associated Press says initial results from a trial of CureVac's SARS-CoV-2 vaccine suggests low effectiveness in preventing COVID-19.

Finding Freshwater DNA

A new research project plans to use eDNA sampling to analyze freshwater rivers across the world, the Guardian reports.

Rise in Payments

Kaiser Health News investigates the rise of payments made by medical device companies to surgeons that could be in violation of anti-kickback laws.

Nature Papers Present Ginkgo Biloba Genome Assembly, Collection of Polygenic Indexes, More

In Nature this week: a nearly complete Ginkgo biloba genome assembly, polygenic indexes for dozens of phenotypes, and more.